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Abstract
Purpose
Obesity influences risk stratification in cardiac surgery in everyday practice. However, some
studies have reported better outcomes in patients with a high body mass index (BMI): this is
known as the obesity paradox. The aim of this study was to quantify the effect of diverse de-
grees of high BMI on clinical outcomes after cardiac surgery, and to assess the existence of
an obesity paradox in our patients.
Methods
A total of 2,499 consecutive patients requiring all types of cardiac surgery with cardiopulmo-
nary bypass between January 2004 and February 2009 were prospectively studied at
our institution. Patients were divided into four groups based on BMI: normal weight (18.5–
24.9 kgm−2; n = 523; 21.4%), overweight (25–29.9kgm−2; n = 1150; 47%), obese (30–
34.9kgm−2; n = 624; 25.5%) and morbidly obese (35kgm−2; n = 152; 6.2%). Follow-up
was performed in 2,379 patients during the first year.
Results
After adjusting for confounding factors, patients with higher BMI presented worse oxygen-
ation and better nutritional status, reflected by lower PaO2/FiO2 at 24h and higher albumin
levels 48h after admission respectively. Obese patients showed a higher risk for Periopera-
tive Myocardial Infarction (OR: 1.768; 95% CI: 1.035–3.022; p = 0.037) and septicaemia
(OR: 1.489; 95% CI: 1.282–1.997; p = 0.005). In-hospital mortality was 4.8% (n = 118) and
1-year mortality was 10.1% (n = 252). No differences were found regarding in-hospital mor-
tality between BMI groups. The overweight group showed better 1-year survival than normal
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weight patients (91.2% vs. 87.6%; Log Rank: p = 0.029. HR: 1.496; 95% CI: 1.062–2.108;
p = 0.021).
Conclusions
In our population, obesity increases Perioperative Myocardial Infarction and septicaemia
after cardiac surgery, but does not influence in-hospital mortality. Although we found better
1-year survival in overweight patients, our results do not support any protective effect of
obesity in patients undergoing cardiac surgery.
Introduction
Obesity is a risk factor for the development of diabetes mellitus, hypertension and coronary ar-
tery disease [1]. Morbid obesity (defined as1.5 ideal weight) and body mass index (BMI) are
included in the Parsonnet system and in the Society of Thoracic Surgeons’ model for stratifica-
tion of the risk for perioperative death [2, 3]. Since mortality risk factors of cardiac surgery and
their incidence in obese patients are largely the same as in patients with normal BMI [4, 5], a
similar outcome seems likely. However, some reports have shown a better survival rate in over-
weight and obese patients than in those with normal BMI. This is currently known as the obesi-
ty paradox [6, 7]. Indeed, increased BMI alone is not related to an increased perioperative risk
in non-cardiac surgery [8] and extreme obesity is not more closely associated with poor surviv-
al than normal weight in the intensive care unit (ICU) [9].
On the other hand, obesity is associated with increased morbidity in the ICU. It markedly
increases the risk of pulmonary and airway complications [10] and hampers tracheal intuba-
tion, mechanical ventilation and weaning, which requires specific ventilatory settings due to
the mechanical and inflammatory alterations observed in this condition [11, 12]. In addition,
obese patients more frequently develop ICU-acquired infections [13]. As a result, obesity is still
regarded as a risk factor for adverse outcomes in the ICU.
The aim of this study was to quantify the effect of diverse degrees of higher BMI on clinical
outcomes (morbidity, in-hospital mortality and 1-year mortality) after cardiac surgery and to
assess the existence of an obesity paradox in our patients.
Methods
Data from this prospective study were collected from 2499 consecutive patients undergoing
different types of cardiac surgery between January 2004 and February 2009 at our institution.
The patients were divided into four groups based on BMI: normal weight (18.5–24.9 kgm−2;
n = 523; 21.4%), overweight (25–29.9kgm−2; n = 1150; 47%), obese (30–34.9 kgm−2; n =
624; 25.5%) and morbidly obese (35kgm−2; n = 152; 6.2%). [1–6]. The underweight group
(n = 24) was excluded from the study due to the low number of patients and events. Emergency
(n = 124) and redo (n = 265) cases were excluded since they might have introduced a
strong bias.
The study was approved by the Institutional Ethics Committee of our hospital (Comité
d'Ètica i Assajos Clínics, Hospital Universitari de Bellvitge). Due to the observational nature of
the study, the Ethics Committee waived the need for consent. The follow-up was performed
using the Catalan Health Central Registry (Registre Central de Persones Assegurades, RCA). A
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complete follow-up for evaluating 1-year mortality was performed in 2379 patients (95.2% of
our study population).
Data on and during ICU admission were extracted from the medical registry of each patient
in real time using a standardized questionnaire and were entered into a database for analysis.
Electronic health records were de-identified prior to use. Recent acute myocardial infarction
(AMI) was defined as an AMI that required admission to the hospital during the month before
surgery or one that prevented discharge from the hospital before surgery. The other definitions
used for this study were based on the Society of Thoracic Surgeons’ national cardiac surgery da-
tabase definitions [14].
Preoperative data (demographic data, co-morbidities and treatment before surgery), opera-
tive data and postoperative variables usually measured on and during admission (including
main outcomes) were recorded together with cardiac surgery scores (Parsonnet, European Sys-
tem for Cardiac Operative Risk Evaluation (EuroSCORE) and ICU scores (Acute Physiology
and Chronic Health Evaluation (APACHE) II and III, Simplified Acute Physiology Score
(SAPS) II and III).
The operations were performed by the same group of cardiac surgeons throughout the
study period. Cardiac procedures were performed in all patients using median sternotomy,
standard cardiopulmonary bypass (CPB) with moderate hypothermia (34°C) and antegrade
cardioplegia. A mean aortic pressure of> 60mmHg was maintained during surgery. Protamine
was administered to reverse heparin, in accordance with standard practice. In all patients, deci-
sions regarding postoperative ICU management were made by the attending physician.
Statistical analysis
Statistical analysis was conducted using PASW statistics 13.0 (SPSS Inc., Chicago, Illinois,
USA). Data are expressed as mean ± standard deviation. ANOVA was used to compare differ-
ences in characteristics and outcome differences between BMI groups, and a subsequent post-
hoc test (Bonferroni test) was used to determine significant differences in the various pairwise
comparisons. In all cases, the Kolmogorov-Smirnov test was used to assess the normal distribu-
tion of our population and the goodness-of-fit of the final regression models.
A propensity score analysis was used to adjust for preoperative and operative confounding
factors in order to minimize baseline differences between the BMI groups. The probability
given by the propensity score was included in the different multivariate analyses. A stepwise lo-
gistic regression model was used to confirm differences between BMI groups. The BMI groups
were included within the models, and the normal weight group was used as control. Survival
analysis was carried out with the Kaplan-Meier estimator for the different BMI groups. A pro-
portional hazards Cox regression model was used to evaluate the effect of staging in a BMI
group on 1-year survival. The calculation of the statistical power of the results was performed
in order to guarantee their appropriateness. A two-tailed p-value of 0.05 was considered
statistically significant.
Results
The median BMI of the whole sample was 28.2±4.1 kgm−2 (range 18.7–50 kgm−2). There was
a low proportion (0.67%; n = 19) of morbidly obese subjects with a BMI40Kgm−2.
The preoperative characteristics of the patients, including treatment before surgery, are
shown in Table 1. Univariate analyses showed higher rates of cardiovascular risk factors such
as hypertension, diabetes mellitus, dyslipidaemia and hypertrophic cardiomyopathy in higher
BMI groups compared with normal weight patients, as well as a higher proportion of treatment
on β-blockers, statins and aspirin. Chronic obstructive pulmonary disease rates were higher in
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Table 1. Distribution of preoperative variables according Body Mass Index group.
Studied
group(n =
2449)
Normal weightBMI =
18.5–24.9kgm−2(n =
523; 21.4%)
OverweightBMI = 25–
29.9kgm−2(n = 1150;
47%)
Obese BMI = 30–
34.9kgm−2 (n =
624; 25.5%)
Morbidly obese
BMI  35 kgm2 (n
= 152; 6.2%)
p-value
Sex (male/female) 1600 / 849 344 / 179 800 / 350 389 / 235 67 / 85 0.15
Age (years) 65.1 ± 11.4 63.8 ± 13.7 65.6 ± 11 65.4 ± 10.2 63.5 ± 10.2 0.012 A
Hypertension 64.8%
(1588)
46.1% (241) 65.6% (754) 76.3% (476) 77% (117) <0.001A,B,C
Diabetes Mellitus 17.9% (438) 13.6% (71) 17.8% (205) 20.2% (126) 23.7% (36) 0.006 A,B,C
Dyslipidemia 52.5%
(1285)
39.2% (205) 54.5% (627) 58.5% (365) 57.9% (88) <0.001
A,B,C
Peripheral vascular
disease
9.4% (229) 9.8% (51) 9.4% (108) 9.3% (58) 7.9% (12) 0.92
Chronic renal
insufﬁciency
4.7% (114) 5.5% (29) 4.7% (54) 4.2% (26) 3.3% (5) 0.59
Renal Failure (on
Dialysis)
0.8% (20) 1.3% (7) 0.9% (10) 0.3% (2) 0.7% (1) 0.69
Creatinine before
surgery (mmolL-1)
95 ± 61 99 ± 81 95 ± 58 93 ± 45 88 ± 56 0.22
Previous Stroke 5.2% (127) 5.2% (27) 5.8% (67) 4.2% (26) 4.6% (7) 0.49
COPD 12.1% (296) 10.1% (53) 10.7% (123) 15.4% (96) 15.8% (24) 0.03B,C
Active smokers 22.9% (562) 26.4% (138) 22% (253) 21.6% (135) 23.7% (36) 0.45
Previous Atrial
Fibrillation
21.9% (538) 22% (115) 23.5% (271) 19.4% (121) 20.4% (31) 0.87
Previous Myocardial
Infarction
17% (417) 14.3% (75) 18.4% (212) 16.8% (105) 16.4% (25) 0.22
Recent Myocardial
Infarction
10.8% (264) 12.2% (64) 10.4% (120) 10.9% (68) 7.9% (12) 0.45
On B-Blockers 43.6%
(1067)
36.7% (192) 44.3% (510) 46.8% (292) 48% (73) 0.03A,B,C
On statins 44.6%
(1093)
35.4% (185) 45.7% (525) 49.5% (309) 48.7% (74) 0.001A,B,C
On Aspirin 48.3%
(1183)
41.5% (217) 48.5% (558) 52.6% (328) 52.6% (80) 0.01A,B,C
On diuretics 45.3%
(1110)
44.9% (235) 44% (506) 46.2% (288) 53.3% (81) 0.28
Hypertrophic
cardiomyopathy
33.6% (823) 23.9% (125) 34.9% (402) 37.5% (234) 40.8% (62) 0.001A,B,C
Dilated
cardiomyopathy
20.4% (500) 22.4% (117) 19.8% (228) 21.1% (132) 15.1% (23) 0.23
LVEF (%) 60.3 ± 11.8 59.7 ± 13 60.5 ± 11.6 60.7 ± 11.5 60.5 ± 10.7 0.53
Hemoglobin before
surgery (gdL−1)
13.1 ± 1.6 12.8 ± 1.6 13.2 ± 1.6 13.2 ± 1.7 13 ± 1.6 0.003A,B
Platelet count before
surgery (1nL−1)
217 ± 69 222± 71 214 ± 66 218 ± 65 224 ± 69 0.061
EuroSCORE 5.4 ± 2.5 5.7 ± 2.6 5.4 ± 2.6 5.1 ± 2.4 5.5 ± 2.3 0.17
Parsonnet score 10.3 ± 5.9 11 ± 6.4 9.9 ± 5.8 10.3 ± 5.9 10.2 ± 4.8 0.02A
COPD = Chronic Obstructive Pulmonary Disease; NYHA = New York Heart Association classiﬁcation; LVEF = Left ventricular ejection fraction;
EuroSCORE = European system for cardiac operative risk evaluation. Results are expressed as mean ± standard deviation or percentage. Statistical
results correspond to ANOVA p values. Bonferroni post hoc testing with statistical signiﬁcant differences:
A between Normal weight and overweight subgroup;
B between Normal weight and obese subgroup;
C between Normal weight and morbidly obese subgroup.
doi:10.1371/journal.pone.0118858.t001
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the obese groups. Patients in the normal group were likely to be younger than those who were
overweight. Haemoglobin before surgery was lower in normal BMI than in the overweight and
obese groups. Patients treated with aspirin did not experience a significant increase in postop-
erative bleeding or requirement for blood products.
The operative characteristics are shown in Table 2. There was a higher proportion of isolat-
ed valve surgery in the normal group, and a higher proportion of Coronary Arterial Bypass
Graft in the higher BMI groups. Surgeries also included in the analysis were: pericardial surgery
0.8% (n = 18), congenital cardiac surgery 1.8% (n = 45), aortic surgery 2.7% (n = 66), and cardi-
ac tumours 1.4% (n = 35).
Differences in postoperative data were observed between BMI groups (Table 2). Obese
groups (obese and morbidly obese) were more likely to be ventilated>24h, suffer from periop-
erative AMI and septicaemia compared with the normal weight group. Regarding episodes of
septicaemia, the main aetiologies were: deep sternal wound infection 0.04% (n = 1), mediastini-
tis 0.12% (n = 3), pneumonia 4.8% (n = 12), and bacteraemia 3.3% (n = 82). Higher BMI
groups had lower arterial oxygen pressure values and lower fraction of inspired oxygen ratio
(PaO2/FiO2) measurements, without any influence on tracheal extubation or respiratory com-
plications. In contrast, they showed higher albumin blood levels 48h after surgery.
The mean ICU stay was longer in the obese groups than in the normal weight group, while
the pre-ICU stay in hospital was shorter in the obese groups. In-hospital mortality was 4.8%
(n = 118). Patients died mainly of multiple organ failure (n = 83; 71%), heart failure (n = 29;
23.9%) and septic shock (n = 6; 5.1%). No differences were found regarding in-hospital mortal-
ity and its causes. Out of 2379 patients, 2139 survived. 1-year mortality was 10.1% (n = 240).
The differences between groups after adjusting for preoperative and postoperative con-
founding factors using a propensity score analysis are shown in Table 3. No differences in hos-
pital mortality were found between normal weight patients and the higher BMI group.
However, the obese group showed higher perioperative AMI and septicaemia compared with
normal weight patients. Higher BMI groups were more likely to have worse PaO2/FiO2 mea-
surements in the first 24h after cardiac surgery and higher albumin blood levels 48h
after surgery.
1-year survival was 89.9%: 87.6% (n = 62/502) for the normal BMI group, 91.2% (n = 98/
1119) for the overweight group, 89.7% (n = 63/609) for the obese group and 88.6% (n = 17/
149) for the morbidly obese. When we analyzed long-term outcome, the overweight group
showed better 1-year survival than the normal weight group when evaluated by Kaplan-Meier
survival analysis (Fig. 1), and confirmed by a proportional hazards Cox regression model (HR:
1.496; 95% CI: 1.062–2.108; p = 0.021).
PaO2/FiO2 measurements in the first 24h and albumin blood levels 48h after surgery results
reached more than 95% statistical power with 95% CI. Results that compare obese group and
normal weight patients showed a statistical power of 70–75% and 75–80% for perioperative
AMI and septicaemia respectively when we analyzed outcomes in those subgroups.
Discussion
Previous studies have postulated the existence of an obesity paradox in terms of in-hospital
and long-term mortality after cardiac surgery [6, 7, 15], despite the association of obesity with
higher rates of cardiovascular risk factors and risk of death in the general population [16].
However, after adjusting for preoperative and operative confounding factors, the present study
did not find that obesity had protective effect; nor did obesity exert any influence over in-hos-
pital mortality, despite higher morbidities during the ICU stay in the higher BMI groups, espe-
cially in obese patients. On the other hand, overweight patients showed better 1-year survival.
Influence of Body Mass Index after Cardiac Surgery
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Table 2. Distribution of intraoperative and postoperative variables according BMI group.
Studied
group (n =
2449)
Normal weight BMI =
18.5–24.9 kgm−2 (n =
523; 21.4%)
Overweight BMI = 25–
29.9 kgm−2 (n = 1150;
47%)
Obese BMI = 30–
34.9 kgm−2 (n =
624; 25.5%)
Morbidly obese BMI
 35 kgm2 (n = 152;
6.2%)
p-value
Intraoperative data
Isolated CABG 35.7% (874) 29.7% (155) 37.4% (430) 38% (237) 34.2% (52) 0.02 A,B,C
Isolated valve 50% (1225) 54.7% (286) 47.5% (546) 49% (306) 57.2% (87) 0.01 A,B,C
CABG+valve 7.6% (186) 8% (42) 8.2% (95) 7.1% (44) 3.3% (5) 0.35
Other cardiac surgery 6.7% (164) 7.6% (40) 6.9% (79) 5.9% (37) 5.3% (8) 0.54
Number of bypass 2.3 ± 0.8 2.3 ± 0.9 2.3 ± 0.8 2.3 ± 0.9 2.5 ± 0.8 0.30
CPB time(min) 110 ± 39 107 ± 37 111 ± 41 112 ± 39 109 ± 33 0.24
ACC time(min) 72 ± 29 71 ± 28 72 ± 30 73 ± 28 70 ± 21 0.59
Postoperative data
SAPS III 39 ± 10 39 ± 10 39 ± 10 38 ± 10 38 ± 8 0.29
APACHE III 48 ± 17 48 ± 17 48 ± 17 48 ± 16 49 ± 15 0.99
Ventilation time
(hours)
41 ± 113 36 ± 99 35 ± 96 52 ± 135 64 ± 165 0.07
Prolonged ventilation
(>24 h)
17.8% (438) 15.1% (79) 16.9% (195) 20% (125) 25.6% (39) 0.001 B,C
PaO2/FiO2 ratio 3 h
after admission
327 ± 91 353 ± 93 327 ± 89 310 ± 85 311 ± 107 <0.001
A,B,C
PaO2/FiO2 ratio 24 h
after admission
311 ± 73 335 ± 73 312 ± 71 296 ± 71 288 ± 76 <0.001
A,B,C
Reintubation 1% (26) 0.9% (5) 1.3% (15) 0.8% (5) 0.6% (1) 0.75
Tracheostomy 1% (24) 0.3% (2) 0.9% (11) 1.1% (7) 2.6% (4) 0.45
Need of vasoactive
drugs (h)
91 ± 125 88 ± 110 85 ± 107 96 ± 147 113 ± 181 0.14
LCOS 39.2% (960) 39% (204) 37.1% (427) 41.7% (260) 45.4% (69) 0.19
PMI 12% (293) 11.8% (62) 11.1% (127) 13.5% (84) 13.2% (20) 0.03 B,C
IABP support 7.5% (185) 6.8% (36) 7.7% (89) 7.7% (48) 7.9% (12) 0.45
Atrial Fibrilation 35% (857) 34.9% (183) 36.8% (424) 31.6% (197) 34.8% (53) 0.37
Creatinine peak after
surgery(mmolL−1)
110 ± 76 112 ± 92 110 ± 75 111 ± 66 102 ± 66 0.62
Acute Renal Failure 7.8% (192) 7.1% (37) 7.4% (85) 9.5% (59) 7.2% (11) 0.38
Albumin 48h after
surgery (gL−1)
28 ± 3.5 27 ± 3.5 28 ± 3.4 28.7 ± 3.7 28.5 ± 3.4 0.001
A,B,C
Hemorrhage-related
reexploration
3.4% (83) 3.8% (20) 4.2% (48) 2.1% (13) 1.3% (2) 0.08
Pericardial
tamponade
0.6% (15) 0.8% (4) 0.5% (6) 0.8% (5) 0 0.65
Drainage loss ﬁrst 12
h (mL)
383 ± 287 392 ± 251 395 ± 307 364 ± 286 344 ± 235 0.08
Re-exploration 1.3% (32) 0.6% (3) 1% (12) 2.4% (15) 1.3% (2) 0.42
Need for blood
products (Units)
1.1 ± 1.7 1.2 ± 1.8 1.1 ± 1.7 1.1 ± 1.5 1 ± 1.7 0.28
Stroke 1.5% (36) 2.1% (11) 1.3% (15) 1.3% (8) 1.3% (2) 0.60
Septicemia 4% (98) 3.8% (20) 2.6% (30) 5.6% (35) 8.5% (13) 0.03 B,C
Mean Pre-ICU stay in
hospital (days)
6.7 ± 8.5 7.8 ± 9.2 6.8 ± 8.4 6 ± 8.2 6.3 ± 7.6 0.002 B
Mean ICU stay (days) 6.6 ± 8.9 6.7 ± 9.3 6 ± 7.1 7.4 ± 11.3 7.8 ± 9.3 0.007 B,C
Mean hospital stay
(days)
23 ± 16.5 24 ± 18 22 ± 15 23 ± 18 24 ± 14 0.09
(Continued)
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Our findings challenge those of previous studies supporting the obesity paradox after cardi-
ac surgery. In those studies, obese patients tended to be referred for surgical revascularization
at a younger age than normal BMI patients due to earlier development of coronary artery dis-
ease [6, 7]; this, together with the high levels of care provided in postoperative follow-up, may
explain their better survival. Conceivably, the obesity paradox may result from direct compari-
sons of the study groups which produced a study bias due to incorrect risk adjustments. To
minimize the risk of this bias, we performed a propensity score analysis in order to correct for
confounding factors [17]. Consistent with epidemiological studies, we found higher cardiovas-
cular risk factor rates in the higher BMI groups, including hypertrophic cardiomyopathy [16].
This condition and obesity itself are associated with diastolic dysfunction and lower coronary
microvascular density in the obese population, which may increase the risk of heart failure [18,
19]. In addition, obese patients are more likely to be receiving preoperative statin treatment,
Table 2. (Continued)
Studied
group (n =
2449)
Normal weight BMI =
18.5–24.9 kgm−2 (n =
523; 21.4%)
Overweight BMI = 25–
29.9 kgm−2 (n = 1150;
47%)
Obese BMI = 30–
34.9 kgm−2 (n =
624; 25.5%)
Morbidly obese BMI
 35 kgm2 (n = 152;
6.2%)
p-value
In-hospital mortality 4.8% (118) 5.2% (27) 4.4% (51) 5.4% (34) 3.9% (6) 0.73
SAPS = Simpliﬁed Acute Physiology Score; APACHE = Acute Physiology and Chronic Health Evaluation; CABG = coronary artery bypass graft; ACC =
Aortic cross clamping; CPB = cardiopulmonary bypass. PaO2/FiO2 = Arterial partial pressure of O2 and fraction of inspired oxygen ratio; LCOS = Low
Cardiac Output Syndrome; PMI = Perioperative Myocardial Infarction; IABP = intra-aortic balloon pump. Results are expressed as mean ± standard
deviation or percentage. Statistical results correspond to ANOVA p values. Bonferroni post hoc testing with statistical signiﬁcant differences:
A between Normal weight and overweight subgroup;
B between Normal weight and obese subgroup;
C between Normal weight and morbidly obese subgroup.
doi:10.1371/journal.pone.0118858.t002
Table 3. Final models of multivariable analysis adjusted by a propensity score showing differences
between Body Mass Index groups.
Odds ratio (95%CI) p-value
Differences between normal and overweight groups
Age 1.010 (0.999–1.020) 0.086
PaO2/FiO2 ratio 3 h after admission 0.998 (0.997–1.000) 0.037
PaO2/FiO2 ratio 24 h after admission 0.996 (0.994–0.998) <0.001
Albumin 48 h after surgery 1.072 (1.031–1.115) <0.001
In-hospital mortality 1.160 (0.564–2.387) 0.687
Differences between normal and obese groups
Perioperative Myocardial Infarction 1.768 (1.035–3.022) 0.037
PaO2/FiO2 ratio 24 h after admission 0.992 (0.989–0.995) <0.001
Albumin 48 h after surgery 1.132 (1.069–1.198) <0.001
Mean ICU stay 1.020 (0.999–1040) 0.058
Septicemia 1.489 (1.282–1.997) 0.005
In-hospital mortality 1.146 (0.498–2.635) 0.75
Differences between normal and morbidily obese groups
Albumin 48 h after surgery 1.138 (1.051–1.233) 0.002
PaO2/FiO2 ratio 24 h after admission 0.991 (0.987–0.994) <0.001
In-hospital mortality 2.435 (0.578–10.249) 0.225
doi:10.1371/journal.pone.0118858.t003
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which is associated with lower biochemical parameters of inflammatory response and myocar-
dial damage following cardiac surgery [20]. Obese patients tend to receive more aggressive car-
dioprotective medication regimens, as was the case in our patients, and may also receive
improved in-hospital management owing to the perceived increased risk. Thus, all these preop-
erative factors, together with the particular baseline differences between groups in each popula-
tion studied and the operative variables shown in the univariate analysis have to be taken into
account in order to perform a propensity score analysis. In addition to these conditions, obese
Fig 1. Kaplan-Meier survival curves comparing normal vs. overweight BMI groups.
doi:10.1371/journal.pone.0118858.g001
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patients have a greater number of atherosclerotic lesions in coronary arteries, even at a younger
age, than the normal body weight or overweight population [21, 22]. They suffer from low-
grade chronic inflammation, which is also related to atherosclerosis and endothelial dysfunc-
tion [23, 24]. In consequence, the higher rates of perioperative AMI that we found in the obese
might be explained by preoperative risk factors and obesity itself.
Cardiac surgery involves a systemic inflammatory response syndrome with the accumula-
tion of both pro- and anti-inflammatory cytokines, which may lead to a worse outcome [25].
Peripheral adipose tissue has been shown to produce soluble cytokine receptors such as tumour
necrosis factor receptors, which are believed to neutralize the harmful effects of cytokines in
the myocardium [26]. Lower systemic vascular resistance, plasma renin activity and renin-an-
giotensin responses, lower levels of atrial natriuretic peptides, and an attenuated sympathetic
nervous system are pathophysiological changes in obese patients that can balance the risk that
obesity itself represents [27]. This may also explain why overweight and obesity are not associ-
ated with higher all-cause and cardiovascular mortality rates in patients with heart failure [28].
At the same time, overweight and obese patients had higher postoperative albumin levels,
which may reflect a preserved or increased lean body mass [29]. The correct functioning of the
immune response system depends on the metabolic response system, and vice versa. As a re-
sult, the overweight and the obese have sufficient nutritional reserve and a more efficient meta-
bolic state, and a better inflammatory and immune response to surgery [30]. This offers a
possible explanation for the potential survival benefit in overweight groups in our population.
Higher septicaemia in obese patients is not a new finding. Sepsis is an important risk factor
for mortality after cardiac surgery, which produces a sepsis-induced cardiac dysfunction per se
[31, 32]. A BMI>30 kgm-2 has been associated with increased sternal wound infection and sa-
phenous vein harvest site infection [33]. Obesity and diabetes (which itself has a high incidence
in obesity) are independent predictors of infection in patients undergoing CABG [34]. Al-
though a high BMI is associated with a higher rate of ICU-acquired urinary tract, pulmonary,
ICU-acquired catheter and blood stream infections, it seems to reduce the risk of death from
septic shock [13, 35, 36]. Finally, hypoalbuminaemia also increases the risk of infection in car-
diac surgery patients [37]. In spite of the lower postoperative albumin levels, normal BMI pa-
tients showed lower rates of septicaemia compared with the obese group. We hypothesised that
obese patients have higher visceral adiposity, which is associated with chronic inflammation
and can aggravate the stress of surgery, leading to an abnormal response in a septic scenario
[29, 30].
Obesity is frequently associated with hypoxaemia (reflected by a low PaO2/FIO2) after
CPB [38] and with a longer time on mechanical ventilation in ICU, especially when BMI is
40kgm−2 [13]. A lower PaO2/FIO2 ratio correlated with the time required to carry out extu-
bation and also with lung injury as a marker for outcome in some types of cardiac surgery [39,
40]. In obesity, end-expiratory lung volume is decreased, leading to impairment in the mechan-
ics of the respiratory system, lung, and chest wall, as well as gas-exchange. Thus, recruitment
maneuvers added to PEEP are crucial to improve oxygenation and compliance without causing
adverse effects on the respiratory function [8, 9]. This may reflect the lack of influence over
mortality despite worse oxygenation after admission in the higher BMI groups.
Our study presents certain limitations. The most important is that it was a single-centre ob-
servational study. Results related with PMI and Septicemia may seem to be slightly underpow-
ered. However, multivariate analysis still confirm these, even if we take into account that the
propensity score equals preoperative factors that may influence in the occurrence of those com-
plications, such as the presence of higher Hypertension rates in the case of PMI and higher Di-
abetes mellitus rates in the case of septicemia. We found a very low incidence of morbidity in
obese patients and a relatively low incidence of highly complex surgical procedures which may
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be due both to the selection bias inherent in a single-centre study and to the optimal postopera-
tive management provided. Among the strengths of this study are the large sample size, which
exceeds that of other contemporary studies [7, 15] and the prospective nature of the data. Fur-
thermore, this investigation was conducted at a large tertiary referral hospital with all the pa-
tients that underwent surgery with CPB, which makes the study population more
homogeneous. In addition, our mortality rates are similar to those reported in other series.
In conclusion, we found higher perioperative AMI and septicaemia after cardiac surgery in
our obese population. Worse oxygenation and better nutritional status were also observed in
patients with higher BMI, reflected by a lower PaO2/FiO2 at 24h and higher albumin levels 48h
after admission respectively. However, there was no difference between groups in terms of in-
hospital mortality. Although we found a better 1-year survival in overweight patients, our re-
sults do not support a protective effect of obesity in patients undergoing cardiac surgery.
Therefore, our findings do not support the obesity paradox concept, which, in our view, may
be the result of study biases. Further studies are needed to examine this issue in greater depth.
Acknowledgments
We would like to thank Michael Maudsley of the University of Barcelona Language Services
for help with the written English.
Author Contributions
Conceived and designed the experiments: JCLD FE CJ JLV RM. Analyzed the data: JCLD FE
CJ KS. Wrote the paper: JCLD JLV RM. Involved in the coordination and the acquisition of
data, even in terms of follow-up: HT MC DRC EF.
References
1. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. (2006) Association
of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a system-
atic review of cohort studies. Lancet 368: 666–78. PMID: 16920472
2. Gabrielle F, Roques F Michel P, Bernard A, de Vicentis C, Roques X, et al. (1997) Is the Parsonnet's
score a good predictive score of mortality in adult cardiac surgery: assessment by a French multicentre
study. Eur J Cardiothorac Surg 11: 406–14. PMID: 9105801
3. Kunt AG, Kurtcephe M, Hidiroglu M, Cetin L, Kucuker A, Bakuy V, et al. (2013) Comparison of original
EuroSCORE, EuroSCORE II and STS risk models in a Turkish cardiac surgical cohort. Interact Cardio-
vasc Thorac Surg 16:625–9. doi: 10.1093/icvts/ivt022 PMID: 23403767
4. Birkmeyer NJ, Charlesworth DC, Hernandez F, Leavitt BJ, Marrin CA, Morton JR, et al. (1998) Obesity
and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England
Cardiovascular Disease Study Group 97: 1689–94. PMID: 9591762
5. Moulton MJ, Creswell LL, Mackey ME, Cox JL, RosenbloomM (1996) Obesity is not a risk factor for sig-
nificant adverse outcomes after cardiac surgery. Circulation 94 (9 Suppl): II87–92. PMID: 8901725
6. Lavie CJ, Milani RVMilani RV, Ventura HO. (2009) Obesity and cardiovascular disease: risk factor, par-
adox, and impact of weight loss. J Am Coll Cardiol 53: 1925–32. doi: 10.1016/j.jacc.2008.12.068
PMID: 19460605
7. Stamou SC, NussbaumM, Stiegel RM, Reames MK, Skipper ER, Robicsek F, et al. (2011) Effect of
body mass index on outcomes after cardiac surgery: is there an obesity paradox? Ann Thorac Surg 91:
42–7. doi: 10.1016/j.athoracsur.2010.08.047 PMID: 21172483
8. Klasen J, Junger A, Hartmann B, Jost A, Benson M, Virabjan T, et al. (2004) Increased body mass
index and peri-operative risk in patients undergoing non-cardiac surgery. Obes Surg 14: 275–81.
PMID: 15027438
9. Martino JL, Stapleton RD, Wang M, Day AG, Cahill NE, Dixon AE, et al. (2011) Extreme obesity and
outcomes in critically ill patients. Chest 140: 1198–206. doi: 10.1378/chest.10-3023 PMID: 21816911
10. Cook TM, MacDougall-Davis SR. (2012) Complications and failure of airway management. Br J
Anaesth 109 (Suppl 1): i68–i85. doi: 10.1093/bja/aes393 PMID: 23242753
Influence of Body Mass Index after Cardiac Surgery
PLOS ONE | DOI:10.1371/journal.pone.0118858 March 17, 2015 10 / 12
11. Leme Silva P, Pelosi P, Rocco PR. (2012) Mechanical ventilation in obese patients. Minerva Anestesiol
78: 1136–45. PMID: 23059518
12. Aldenkortt M, Lysakowski C, Elia N, Brochard L, Tramèr MR. (2012) Ventilation strategies in obese pa-
tients undergoing surgery: a quantitative systematic review and meta-analysis. Br J Anaesth 109: 493–
502. doi: 10.1093/bja/aes338 PMID: 22976857
13. Sakr Y, Madl C, Filipescu D, Moreno R, Groeneveld J, Artigas A, et al. (2008) Obesity is associated
with increased morbidity but not mortality in critically ill patients. Intensive Care Med 34: 1999–2009.
doi: 10.1007/s00134-008-1243-0 PMID: 18670756
14. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. (2004) ACC/AHA 2004
guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiolo-
gy/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999
Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110: e340–437. PMID: 15466654
15. Vaduganathan M, Lee R, Beckham AJ, Andrei AC, Lapin B, Stone NJ, et al. (2012) Relation of body
mass index to late survival after valvular heart surgery. Am J Cardiol 110: 1667–78. doi: 10.1016/j.
amjcard.2012.07.041 PMID: 22921997
16. Hubert HB, Feinleib M, McNamara PM, Castelli WP. (1983) Obesity as an independent risk factor for
cardiovascular disease: a 26-year follow-up of participants in the FraminghamHeart Study. Circulation
67: 968–77. PMID: 6219830
17. Arbogast PG, RayWA. (2011) Performance of disease risk scores, propensity scores, and traditional
multivariable outcome regression in the presence of multiple confounders. Am J Epidemiol 174:613–
20. doi: 10.1093/aje/kwr143 PMID: 21749976
18. Campbell DJ, Somaratne JB, Prior DL, Yii M, Kenny JF, Newcomb AE, et al. (2013) Obesity is associat-
ed with lower coronary microvascular density. PLoS One 8: e81798. doi: 10.1371/journal.pone.
0081798 PMID: 24312359
19. Kilger E, Heyn J, Beiras-Fernandez A, Luchting B, Weis F (2011). Stress doses of hydrocortisone re-
duce systemic inflammatory response in patients undergoingcardiac surgery without cardiopulmonary
bypass. Minerva Anestesiol 77: 268–74. PMID: 21441882
20. Martínez-Comendador JM, Alvarez JR, Mosquera I, Sierra J, Adrio B, Carro JG, et al. (2009) Preopera-
tive statin treatment reduces systemic inflammatory response and myocardial damage in cardiac sur-
gery. Eur J Cardiothorac Surg 36: 998–1005. doi: 10.1016/j.ejcts.2009.05.022 PMID: 19581104
21. Pietrucha AZ, Stryjewski PJ, El-Massri N, Gajos G, Kruszelnicka O, Badacz L, et al. (2011) The influ-
ence of obesity on progression of coronary arteriosclerosis and clinical course after ST elevation acute-
myocardial infarction treated with primary coronary interventions. Adv Med Sci 56:241–8. doi: 10.2478/
v10039-011-0054-7 PMID: 22119914
22. McGill HC Jr, McMahan CA, Herderick EE, Zieske AW, MalcomGT, Tracy RE, et al; Pathobiological
Determinants of Atherosclerosis in Youth (PDAY) Research Group. (2002) Obesity accelerates the pro-
gression of coronary atherosclerosis in young men Circulation 105: 2712–8. PMID: 12057983
23. Hulsmans M, Geeraert B, De Keyzer D, Mertens A, Lannoo M, Vanaudenaerde B, et al. (2012) Interleu-
kin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome.
PLoS One 7:e30414. doi: 10.1371/journal.pone.0030414 PMID: 22272346
24. Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Russo PE, et al. (2014) Adipose tissue and
vascular inflammation in coronary artery disease. World J Cardiol 6: 539–54. doi: 10.4330/wjc.v6.i7.
539 PMID: 25068015
25. Gustafsson F, Kragelund CB, Torp-Pedersen C, Seibaek M, Burchardt H, Akkan D, et al; DIAMOND
study group. (2005) Effect of obesity and being overweight on long-term mortality in congestive heart
failure: influence of left ventricular systolic function. Eur Heart J 26: 58–64. PMID: 15615800
26. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. (1999) Production of solu-
ble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277:
E971–5. PMID: 10600783
27. Oreopoulos A, Padwal RError! Hyperlink reference not valid., Kalantar-Zadeh K, Fonarow GC, Nor-
ris CM, McAlister FA. (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart
J 156:13–22. doi: 10.1016/j.ahj.2008.02.014 PMID: 18585492
28. Tosa S, Watanabe H, Iino K, Terui G, Kosaka T, Hasegawa H, et al. (2009) Usefulness of plasma BNP
levels as a marker of left ventricular wall stress in obese individuals. Int Heart J 50: 173–82. PMID:
19367028
29. Valentijn TM, Galal W, Tjeertes EK, Hoeks SE, Verhagen HJ, Stolker RJ. (2013) The obesity paradox
in the surgical population. Surgeon 11: 169–76. doi: 10.1016/j.surge.2013.02.003 PMID: 23490287
30. Hotamisligil GS. (2006) Inflammation and metabolic disorders. Nature 444: 860–7. PMID: 17167474
Influence of Body Mass Index after Cardiac Surgery
PLOS ONE | DOI:10.1371/journal.pone.0118858 March 17, 2015 11 / 12
31. Rahmanian PB, Adams DH, Castillo JG, Carpentier A, Filsoufi F. (2010) Predicting hospital mortality
and analysis of long-term survival after major noncardiac complications in cardiac surgery patients.
Ann Thorac Surg 90: 1221–9. doi: 10.1016/j.athoracsur.2010.05.015 PMID: 20868817
32. Rudiger A, Singer M. (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:
1599–608. PMID: 17452940
33. Engelman DT, Adams DHError! Hyperlink reference not valid., Byrne JG, Aranki SF, Collins JJ Jr,
Couper GS, et al. (1999) Impact of body mass index and albumin on morbidity and mortality after cardi-
ac surgery. J Thorac Cardiovasc Surg 118: 866–73. PMID: 10534692
34. Ahmed D, Cheema FH Cheema FH, Ahmed YI, Schaefle KJ, Azam SI, Sami SA, et al. (2011) Incidence
and predictors of infection in patients undergoing primary isolated coronary artery bypass grafting: a re-
port from a tertiary care hospital in a developing country. J Cardiovasc Surg (Torino) 52: 99–104.
PMID: 21224817
35. Wurzinger B, Dünser MW,Wohlmuth C, Deutinger MC, Ulmer H, Torgersen C, et al. (2010) The associ-
ation between body-mass index and patient outcome in septic shock: a retrospective cohort study.
Wien Klin Wochenschr 122: 31–6. doi: 10.1007/s00508-010-1435-9 PMID: 20924702
36. Dossett LA, Dageforde LA, Swenson BR, Metzger R, Bonatti H, Sawyer RG, et al. (2009) Obesity and
site-specific nosocomial infection risk in the intensive care unit. Surg Infect (Larchmt) 10:137–42. doi:
10.1089/sur.2008.028 PMID: 19388836
37. Rapp-Kesek D, Ståhle E, Karlsson TT. (2004) Body mass index and albumin in the preoperative evalu-
ation of cardiac surgery patients. Clin Nutr 23: 1398–404. PMID: 15556262
38. Ranucci M, Ballotta A, La Rovere MT, Castelvecchio S; Surgical and Clinical Outcome Research
(SCORE) Group (2014). Postoperative hypoxia and length of intensive care unit stay after cardiac sur-
gery: the underweight paradox? PLoS One 9: e93992. doi: 10.1371/journal.pone.0093992 PMID:
24709952
39. Kurabayashi M, Okishige K, Azegami K, Ueshima D, Sugiyama K, Shimura T, et al. (2010) Reduction
of the PaO2/FiO2 ratio in acute aortic dissection—relationship between the extent of dissection and in-
flammation—.Circ J 74: 2066–73. PMID: 20697178
40. Sá MP, Nogueira JR, Ferraz PE, Figueiredo OJ, Cavalcante WC, Cavalcante TC, et al. (2012) Risk fac-
tors for low cardiac output syndrome after coronary artery bypass grafting surgery. Rev Bras Cir Cardio-
vasc 27: 217–23. PMID: 22996972
Influence of Body Mass Index after Cardiac Surgery
PLOS ONE | DOI:10.1371/journal.pone.0118858 March 17, 2015 12 / 12
